What is the treatment for Traveler's Diarrhea (TD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Traveler's Diarrhea (TD) treatment should start with supportive measures such as rehydration and non-antibiotic, anti-motility drugs like loperamide for mild cases.

Treatment Approach

  • For mild diarrhea, loperamide is recommended as the first-line treatment, with a starting dose of 2 tablets (4 mg), followed by 2 mg after each additional loose or liquid stool, up to a total dose of 16 mg per day 1.
  • Antibiotics should be reserved for moderate to severe cases, or when symptoms worsen or are accompanied by fever, abdominal pain, or bloody diarrhea.
  • Azithromycin is recommended as the first-line antibiotic for dysentery and acute watery diarrhea with fever, due to its efficacy against FQ-resistant Campylobacter and other bacterial causes 1.
  • Rifaximin, a nonabsorbable antibiotic, is an alternative for non-invasive TD caused by diarrheagenic E. coli, but is less effective for invasive pathogens 1.

Considerations

  • The decision to treat TD with antibiotics should balance the benefits of symptom reduction against the risks of antibiotic resistance, side effects, and impact on the individual's microbiota 1.
  • Single-dose regimens may minimize the risk of adverse consequences, but more research is needed to confirm this 1.
  • Fluoroquinolones (FQs) are effective but may have concerns regarding resistance, side effects, and potential for C. difficile infection 1.

From the Research

Treatment Options for Traveler's Diarrhea

The treatment for Traveler's Diarrhea (TD) depends on the severity of the symptoms. According to 2, 3, 4, 5, 6, the mainstay of treatment includes:

  • Antibacterial therapy with one of three drugs: a fluoroquinolone, rifaximin, or azithromycin
  • Probiotics have been used in preliminary studies for both treatment and prevention of TD, but more studies are needed with these biologic agents

Mild Traveler's Diarrhea

For mild cases, the use of antibiotics is not recommended 5. Instead:

  • Bismuth subsalicylate or loperamide may be considered for treatment
  • Loperamide may be used alone for treatment of mild TD

Moderate Traveler's Diarrhea

For moderate cases, antibiotics such as:

  • Fluoroquinolones
  • Azithromycin
  • Rifaximin may be used 3, 5. Loperamide may be considered as monotherapy or adjunctive therapy.

Severe Traveler's Diarrhea

For severe cases, antibiotics such as:

  • Azithromycin
  • Fluoroquinolones
  • Rifaximin should be used 5. Azithromycin can be used even for the treatment of dysentery, whereas fluoroquinolones and rifaximin cannot be used for such purpose.

Single-Dose Antibiotic Regimens

A randomized controlled trial compared 3 single-dose antibiotic regimens with loperamide for the treatment of TD 4. The results showed that:

  • Single-dose azithromycin, levofloxacin, and rifaximin with loperamide were comparable for treatment of acute watery diarrhea
  • Clinical cure at 24 hours occurred in 81.4%, 78.3%, and 74.8% of the levofloxacin, azithromycin, and rifaximin arms, respectively

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Advances in the treatment of travelers' diarrhea.

Current gastroenterology reports, 2011

Research

Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Research

Travelers' Diarrhea: A Clinical Review.

Recent patents on inflammation & allergy drug discovery, 2019

Research

Traveler's diarrhea.

American family physician, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.